PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response

被引:421
|
作者
Zhang, Feng [2 ]
Ma, Jianglin [1 ]
Wu, Jiaxue [2 ]
Ye, Lin [2 ]
Cai, Hong [1 ]
Xia, Bing [1 ]
Yu, Xiaochun [2 ]
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, Canc Inst New Jersey, New Brunswick, NJ 08903 USA
[2] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
FANCONI-ANEMIA; CANCER SUSCEPTIBILITY; S-PHASE; PHOSPHORYLATION; ATM; BACH1; RECOMBINATION; CHECKPOINT; PARTNER; PROTEIN;
D O I
10.1016/j.cub.2009.02.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BRCA1 and BRCA2 are often mutated in familial breast and ovarian cancer. Both tumor suppressors play key roles in the DNA-damage response [1, 2]. However, it remains unclear whether these two tumor suppressor function together in the same DNA-damage response pathway. Here, we show that BRCA1 associates with BRCA2 through PALB2/FANCN, a major binding partner of BRCA2 [3]. The interaction between BRCA1 and BRCA2 is abrogated in PAL132-deficient Fanconi anemia cells and in the cells depleted of PALB2 by small interfering RNA. Moreover, we show that BRCA1 promotes the concentration of PALB2 and BRCA2 at DNA-damage sites and the interaction between BRCA1 and PALB2 is important for the homologous recombination repair. Taken together, our results indicate that BRCA1 is an upstream regulator of BRCA2 in the DNA-damage response, and PALB2 is the linker between BRCA1 BRCA2.
引用
收藏
页码:524 / 529
页数:6
相关论文
共 50 条
  • [41] BRCA1 and BRCA2: Breaking the cycle and repairing the damage
    Barwell, J
    Georgiou, A
    Pangon, L
    Kesterton, I
    Gilchrist, R
    Ball, J
    Arden-Jones, A
    Hamed, H
    Wilkinson, L
    Solomon, E
    Camplejohn, R
    Docherty, Z
    Berg, J
    Eeles, R
    Hodgson, S
    JOURNAL OF MEDICAL GENETICS, 2004, 41 : S67 - S67
  • [42] Frequent Abnormal Pancreas Imaging in Patients With Pathogenic ATM, BRCA1, BRCA2, and PALB2 Breast Cancer Susceptibility Variants
    Lucas, Aimee L.
    Fu, Yichun
    Labiner, Arielle J.
    Dimaio, Christopher J.
    Sethi, Amrita
    Kastrinos, Fay
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (10) : 2686 - 2688
  • [43] Beyond BRCA1 and BRCA2
    King-Spohn, Kimberly
    Pilarski, Robert
    CURRENT PROBLEMS IN CANCER, 2014, 38 (06) : 235 - 248
  • [44] In Brief: BRCA1 and BRCA2
    Foulkes, William D.
    Shuen, Andrew Y.
    JOURNAL OF PATHOLOGY, 2013, 230 (04): : 347 - 349
  • [45] Association between single nucleotide polymorphisms of DNA repair genes (BRCA1, BRCA2, and PALB2) and breast cancer incidence in a subset of Iranian population
    Jahangiri, Sepideh
    Abdan, Zahra
    Houshmand, Massoud
    Souroush, Ali
    Aznab, Mozaffar
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2025, 23 (01)
  • [46] The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives
    Cao, A-Yong
    Huang, Juan
    Hu, Zhen
    Li, Wen-Feng
    Ma, Zhong-Liang
    Tang, Li-Li
    Zhang, Bin
    Su, Feng-Xi
    Zhou, Jie
    Di, Gen-Hong
    Shen, Kun-Wei
    Wu, Jiong
    Lu, Jin-Song
    Luo, Jian-Min
    Yuan, Wen-Tao
    Shen, Zhen-Zhou
    Huang, Wei
    Shao, Zhi-Ming
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 114 (03) : 457 - 462
  • [47] Mutation analysis of PALB2 in high-risk and lower-risk patients negative for BRCA1 and BRCA2 mutations.
    Cummings, Shelly
    Peterson, Jenny
    Hughes, Elisha
    Kaldate, Rajesh R.
    Chen, Sonia
    Trost, Jeffrey T.
    Arnell, Christopher
    Saam, Jennifer R.
    Roa, Benjamin
    Fernandes, Priscilla H.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [48] Germline pathogenic variants in BRCA1, BRCA2, PALB2 and RAD51C in breast cancer women from Argentina
    Cerretini, Roxana
    Mercado, Graciela
    Morganstein, Josh
    Schiaffi, Jorge
    Reynoso, Monica
    Montoya, Diana
    Valdez, Rita
    Narod, Steven A.
    Akbari, Mohammad R.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 178 (03) : 629 - 636
  • [49] The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives
    A-Yong Cao
    Juan Huang
    Zhen Hu
    Wen-Feng Li
    Zhong-Liang Ma
    Li-Li Tang
    Bin Zhang
    Feng-Xi Su
    Jie Zhou
    Gen-Hong Di
    Kun-Wei Shen
    Jiong Wu
    Jin-Song Lu
    Jian-Min Luo
    Wen-Tao Yuan
    Zhen-Zhou Shen
    Wei Huang
    Zhi-Ming Shao
    Breast Cancer Research and Treatment, 2009, 114 : 457 - 462
  • [50] Interaction with PALB2 Is Essential for Maintenance of Genomic Integrity by BRCA2
    Hartford, Suzanne A.
    Chittela, Rajanikant
    Ding, Xia
    Vyas, Aradhana
    Martin, Betty
    Burkett, Sandra
    Haines, Diana C.
    Southon, Eileen
    Tessarollo, Lino
    Sharan, Shyam K.
    PLOS GENETICS, 2016, 12 (08):